Newsroom

PARIS--(BUSINESS WIRE)--Regulatory News: Advicenne (Euronext Growth Paris ALDVI - FR0013296746), société pharmaceutique spécialisée dans le développement et la commercialisation de traitements innovants pour les personnes souffrant de maladies rénales rares, annonce aujourd’hui l’inscription de Likozam® (clobazam) sur la liste des médicaments remboursables aux assurés sociaux et agréés à l'usage des collectivités et divers services publics, notamment dans le traitement en association des épilep...

PARIS--(BUSINESS WIRE)--Regulatory News: Advicenne (Euronext Growth Paris - FR0013296746 - ALDVI), a pharmaceutical company specializing in the development and marketing of innovative treatments for people suffering from rare kidney diseases, announced today that Likozam® (clobazam) is reimbursed by the French social security system, notably for the combination treatment of drug-resistant epilepsy. The price of Likozam® in France, as published in the Official Journal, is: €92.24 including taxes...

TAIPEI, Taiwan--(BUSINESS WIRE)--Uber (NYSE: UBER), and Autobrains announced at GTC Taipei today a strategic collaboration to launch a robotaxi program in Munich, combining Uber’s ride-hailing platform, Autobrains’ agentic autonomous driving intelligence, and NVIDIA DRIVE robotaxi-ready level 4 Hyperion platform to support scalable autonomous mobility for commercial ride-hailing. Pending regulatory approval, Munich will serve as the first deployment city for the robotaxi program, establishing a...

HOUSTON & TAIPEI, Taiwan--(BUSINESS WIRE)--COMPUTEX – HPE (NYSE: HPE) today announced the expansion of its industry-leading server portfolio with the introduction of the HPE ProLiant Compute DL394 Gen12, powered by NVIDIA Vera CPU. This next-generation server is engineered specifically to address the compute demands of emerging high-performance AI and data processing workloads delivering industry-leading agentic AI CPU performance, memory bandwidth, and low latency. Built on a foundation of adv...

BREMEN--(BUSINESS WIRE)--Synera, die agentische KI-Plattform für die gesamte Wertschöpfungskette der Produktentwicklung, ist eines der ersten Unternehmen im Bereich Design und Simulation, das mit NVIDIA NemoClaw zusammenarbeitet. NemoClaw ist ein Blueprint zur Entwicklung spezialisierter KI-Agenten, die lang andauernde Engineering-Workflows sicher, zuverlässig und im Enterprise-Maßstab ausführen können. Mit diesem Meilenstein reiht sich Synera in eine ausgewählte Gruppe von Softwareunternehmen...

BREMEN, Germany--(BUSINESS WIRE)--Synera's collaboration with NVIDIA highlights the growing role of agentic AI in transforming physical product development....

SAN JOSE, Calif.--(BUSINESS WIRE)--At Computex 2026, Cadence (Nasdaq: CDNS) announced the industry’s first fully autonomous virtual agentic AI design engineer, extending the ChipStack™ AI Super Agent to Level-5 autonomy. Built on Cadence’s AI-driven electronic design automation (EDA) portfolio with NVIDIA Nemotron models, and secured by NVIDIA OpenShell runtime, the new agentic capabilities enable customers to run dynamic simulations in automated workflows. At NVIDIA, 1000s of engineers are usi...

EINDHOVEN, Netherlands--(BUSINESS WIRE)--Invisix, the semiconductor metrology company developing next-generation measurement tools for advanced chip manufacturing, has raised an oversubscribed €20 million seed round, which includes Hitachi Ventures, Transition Ventures, imec.xpand, Doosan Investment Co., and a tier-1 semiconductor manufacturer. The funding will be used to grow the Invisix team, accelerate development of its first shippable system, and support customer demonstrations at a new cl...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that new data from its obesity portfolio will be presented at the 2026 Scientific Sessions of the American Diabetes Association® (ADA). The insights demonstrate significant progress in addressing a range of unmet needs for people living with obesity or overweight such as long-term treatment adherence, which could be supported by a favorable safety and tolerability p...

KYOTO, Japan--(BUSINESS WIRE)--Nidec Corporation (TOKYO: 6594; OTC US: NJDCY) (the “Company” or “we”) hereby announces that Glass Lewis & Co., LLC (“Glass Lewis”), a leading proxy advisory firm, has issued a report recommending that shareholders vote “FOR” all proposals to be entered at the Company’s upcoming 53rd Regular General Meeting of Shareholders scheduled for June 18, 2026. The proposals: 1. Partial Amendments to the Articles of Incorporation 2. Election of eight Members of the Boar...